Table 1. Patient characteristics.
| Characteristics | No. of patients (%) |
|---|---|
| Age (years) | |
| Median (range) | 71.0 (65.0-81.0) |
| ECOG performance status | |
| 0-1 | 108 (81.2) |
| ≥ 2 | 25 (18.8) |
| BMI (kg/m2) | |
| < 30 | 96 (72.2) |
| ≥ 30 | 37 (27.8) |
| WIC | |
| ≥ 1 | 52 (39.1) |
| < 1 | 81 (60.9) |
| Baseline LVEF | |
| Median (range) | 61% (47.0–69.0) |
| TNM stage | |
| I-II | 39 (29.3) |
| III | 61 (45.9) |
| IV | 33 (24.8) |
| Anthracycline exposure | |
| Previous | 49 (36.8) |
| Concomitant | 22 (16.5) |
| None | 62 (46.6) |
| Anthracycline cumulative dose (mg/m2) | 116 (0-540) |
| Previous radiotherapy (thoracic wall) | |
| Yes | 19 (14.3) |
| No | 124 (93.2) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; WIC, Charlson’s weighted index of comorbidities; LVEF, left ventricular ejection fraction; CT, chemotherapy